drugset / Trial / NCT00132548
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
Phase 3
Completed
2200 enrolled
London School of Hygiene and Tropical Medicine
Cheikh Anta Diop University, Senegal · collabInstitut de Recherche pour le Developpement, Senegal · collabMinistry of Health, Senegal · collab
RandomizedSingle-groupSingle-blindPrevention
Summary
A recent study has shown that the administration of a single dose of sulfadoxine/pyrimethamine plus artesunate to Senegalese children on three occasions during a short malaria transmission season reduced the incidence of clinical attacks of malaria by 86%. However, use of this drug regimen led to the selection of parasites with molecular markers of resistance to pyrimethamine and sulfadoxine. Therefore, a trial of three alternative regimens has been undertaken to see if these are as effective and safe as the drug combination used in the initial study but less likely to select for drug resistance.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | — | — |
| Subject | amodiaquine | Other / unclassified | — | — |
| Subject | pyrimethamine | Small molecule | — | — |
| Subject | sulfadoxine | Small molecule | — | — |